David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
T-Mobile US
TMUS
|
+$911M |
| 4 |
Netflix
NFLX
|
+$699M |
| 5 |
Micron Technology
MU
|
+$672M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$768M |
| 2 |
Robinhood
HOOD
|
+$643M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$534M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Intuit
INTU
|
+$472M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.33% |
| 2 | Healthcare | 8.66% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
SunCoke Energy
SXC
$816M
| $13.3M | 0.01% |
1,550,973
-387,773
| -20% | -$3.36M |
|
|
MRX
1202
Marex Group Limited Ordinary Shares
MRX
$5.07B
| $13.3M | 0.01% |
+337,193
| New | +$14M |
|
1203
Kemper
KMPR
$1.63B
| $13.3M | 0.01% |
206,139
+167,482
| +433% | +$10.4M |
|
1204
RLX Technology
RLX
$2.21B
| $13.3M | 0.01% |
6,017,137
+1,567,208
| +35% | +$3.06M |
|
1205
Verra Mobility
VRRM
$679M
| $13.3M | 0.01% |
522,429
-298,710
| -36% | -$6.96M |
|
1206
Ezcorp Inc
EZPW
$2.15B
| $13.2M | 0.01% |
954,441
-941,399
| -50% | -$13.6M |
|
1207
CALL
Five Below
FIVE
$14.5B
| $13.2M | 0.01% |
100,900
+97,300
| +2,703% | +$9.48M |
|
1208
PUT
On Holding
ONON
$9.86B
| $13.2M | 0.01% |
253,900
+10,600
| +4% | +$540K |
|
1209
PUT
Boston Scientific
BSX
$71B
| $13.2M | 0.01% |
123,000
+67,400
| +121% | +$6.82M |
|
1210
Live Oak Bancshares
LOB
$1.87B
| $13.2M | 0.01% |
442,173
+57,687
| +15% | +$1.56M |
|
1211
Hovnanian Enterprises
HOV
$739M
| $13.2M | 0.01% |
125,991
-6,483
| -5% | -$635K |
|
1212
Celldex Therapeutics
CLDX
$3.19B
| $13.1M | 0.01% |
645,657
+239,496
| +59% | +$4.66M |
|
1213
CALL
Cadence Design Systems
CDNS
$87B
| $13.1M | 0.01% |
+42,600
| New | +$12.4M |
|
1214
CALL
Regeneron Pharmaceuticals
REGN
$85.3B
| $13.1M | 0.01% |
25,000
-13,300
| -35% | -$7.42M |
|
1215
Apollo Global Management
APO
$78.4B
| $13.1M | 0.01% |
92,390
-1,569,337
| -94% | -$208M |
|
1216
CALL
Toast
TOST
$21.2B
| $13.1M | 0.01% |
295,700
-81,200
| -22% | -$3.19M |
|
|
ALF
1217
Centurion Acquisition Corp
ALF
$390M
| $13.1M | 0.01% |
1,237,500
| – | – |
|
1218
Blackstone
BX
$108B
| $13.1M | 0.01% |
87,517
+49,076
| +128% | +$6.74M |
|
1219
SEI Investments
SEIC
$13.3B
| $13.1M | 0.01% |
+145,566
| New | +$11.7M |
|
1220
Pinterest
PINS
$13.3B
| $13.1M | 0.01% |
364,063
-437,985
| -55% | -$13.3M |
|
1221
ACI Worldwide
ACIW
$5.29B
| $13.1M | 0.01% |
284,339
+269,840
| +1,861% | +$13.3M |
|
1222
Cooper-Standard Automotive
CPS
$471M
| $13M | 0.01% |
605,904
+462,183
| +322% | +$8.9M |
|
1223
The RealReal
REAL
$1.37B
| $13M | 0.01% |
2,715,201
-1,329,951
| -33% | -$7.32M |
|
|
ACH
1224
Accendra Health
ACH
$89.2M
| $13M | 0.01% |
1,429,063
+616,830
| +76% | +$4.55M |
|
1225
Credicorp
BAP
$30.2B
| $13M | 0.01% |
58,168
-61,211
| -51% | -$12.4M |
|
Similar funds
David Shaw's Q2 2025 Portfolio in Review
As of Q2 2025, David Shaw held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.
- David Shaw's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
- David Shaw added most to Apple in Q2 2025, an estimated $1.2B increase.
- David Shaw's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
- David Shaw fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
- David Shaw's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
- David Shaw opened 647 new positions and closed 532 in Q2 2025.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $141B.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.